Sanofi SA vs Wynn Resorts, Limited — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while Wynn Resorts, Limited trades at $95.88 (market cap $9.93B). The key difference: Sanofi SA is far larger — about 10.6× Wynn Resorts, Limited's market cap, and Sanofi SA pays the higher dividend (5.5%). Which is the better fit depends on your goals.
| SNY | WYNN | |
|---|---|---|
Market Cap | $104.83B | $9.93B |
Sector | Health | Consumer Cyclical |
52-Week High | $52.34 | $133.34 |
52-Week Low | $41.33 | $94.78 |
Enterprise Value | $121.32B | $20.29B |
Dividend Yield | 5.5% | 1.05% |
Trailing returns across standard periods
Latest headlines on both assets
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four megaresorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, Encore Boston Harbor in Massachusetts opened June 2019. Additionally, we expect the company to begin construction on a new building next to its existing Macao Palace resort in 2023, which we forecast to open in 2026. The company also operates Wynn Interactive, a digital sports betting and iGaming platform. The company received 76% and 24% of its 2019 prepandemic EBITDA from Macao and Las Vegas, respectively.
Read more on WYNN →